Become a member

Cart (0)

Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Sheraton Philadelphia University City

Oct 23, 2017 7:30 AM - Oct 26, 2017 5:00 PM

3549 Chestnut Street, Philadelphia, PA 19104

Regulatory Affairs: The IND, NDA, and Postmarketing

Back to Agenda

Session 20: Post-NDA Approval Regulatory Requirements

Session Chair(s)

Michael Hamrell, PhD, RAC

Michael Hamrell, PhD, RAC

President

MORIAH Consultants, United States

Post-NDA Approval Obligations
Postmarketing (Phase 4) Requirements and Commitments
Supplements and other Changes to an Approved Application
Postmarketing Reporting of Adverse Drug Experiences
15-Day Alert Reports
NDA Annual Reports
NDA Field Alert Reports
Biologic Product Deviation Reports
Drug Registration and Listing

Have an account?